Verification evidence is still being completed.
PDF / print export
Lead Biologics
Helsingborg, Sweden
- Verified lead
- Anki Malmborg Hager
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO
- 2026 technical specialization
- Antibody Therapeutics, Biologics Discovery, Drug Development, and Biotech
- Review cycle
- May 2026
- Full address
- Lead Biologics AB, Box 23163, SE-250 23 Helsingborg, Sweden
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Lead Biologics contact page confirming the Helsingborg address.
- Editorial note
- Lead Biologics is published because official company materials confirm current leadership, Helsingborg operating address, and a clear antibody-therapeutics platform.
Antibody Therapeutics, Biologics Discovery, Drug Development, and Biotech
Official leadership disclosure, Official Helsingborg address disclosure, Biologics platform claim
Lead Biologics is published because official company materials confirm current leadership, Helsingborg operating address, and a clear antibody-therapeutics platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated25 Aug 2026, 15:57
Company profile · Helsingborg, Sweden
Lead Biologics
Antibody Therapeutics, Biologics Discovery, Drug Development, and Biotech · Development-stage biologics platform
Verified 22 Mar 2026 · 2 sources
BiologicsDiscovery
Lead Biologics runs biologics discovery, antibody program development, and therapeutics platform work in Helsingborg, Sweden.
Contact & location
- Website
- leadbiologics.com
- Lead
- Anki Malmborg Hager (verified ↗)
- Compliance
- Not yet on record
- Last reviewed
- 22 Mar 2026 (5mo ago)
- Scale
- Development-stage biologics platform
- Capabilities
- Biologics Discovery · Antibody Program Development · Therapeutics Platform Work
- Founded
- 2020
- Headcount
- 1-10
Antibody Therapeutics, Biologics Discovery, Drug Development, and Biotech
Lead Biologics is published because official company materials confirm current leadership, Helsingborg operating address, and a clear antibody-therapeutics platform.
Editorial note
Lead Biologics is published because official company materials confirm current leadership, Helsingborg operating address, and a clear antibody-therapeutics platform.
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Verification details
Clinical profileSTATUS: VERIFIED MARCH 2026
Anki Malmborg Hager
CEO
Full addressLead Biologics AB, Box 23163, SE-250 23 Helsingborg, Sweden
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official Lead Biologics contact page listing the Helsingborg address and CEO contact.
Open sourceDevelopment-stage biologics platform
Helsingborg, Sweden. Antibody Therapeutics, Biologics Discovery, Drug Development, and Biotech. Review completed on 22 Mar 2026.
Swedish corporate and therapeutics-development oversight
Official leadership disclosure, Official Helsingborg address disclosure, Biologics platform claim
Capabilities
Biologics Discovery
Antibody Program Development
Therapeutics Platform Work
Sources
The official sources used to verify this profile.
Infrastructure
Biologics discovery workflow
Antibody development systems
Therapeutics program infrastructure
Certifications
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Review log
22 Mar 2026: Executive identity confirmed via official management disclosure.
22 Mar 2026: All seven review areas are complete.
Frequently asked questions
- Where is Lead Biologics located?
- Lead Biologics operates from Lead Biologics AB, Box 23163, SE-250 23 Helsingborg, Sweden, Helsingborg, Sweden.
- Who runs Lead Biologics?
- Lead Biologics is led by Anki Malmborg Hager, CEO. Verified 22 Mar 2026.
- What does Lead Biologics do?
- Lead Biologics runs biologics discovery, antibody program development, and therapeutics platform work in Helsingborg, Sweden. Core capabilities: Biologics Discovery, Antibody Program Development, Therapeutics Platform Work.
Editorial context
Related technical briefs
Briefs that name Helsingborg as a covered market or city.